Sun Pharma Strengthens Oncology Portfolio with $355 Million Acquisition of Checkpoint Therapeutics
India’s Sun Pharmaceutical Industries has made a significant move in oncology and immunotherapy with its latest acquisition of Checkpoint Therapeutics, a US-based targeted oncology company, for $355 million. This deal…